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Endocytosisa-Synuclein (a-syn) can be secreted from neurons into the extracellular space, affecting the homeo-
stasis of neighboring cells, but the pathophysiology of secreted a-syn remains largely unknown. We
found that when exogenously applied to COS-7 cells, a-syn secreted from differentiated SH-SY5Y
cells was taken up by dynamin-dependent endocytosis. Upon internalization, a-syn signiﬁcantly
increased the rate of transferrin receptor (TfR) internalization and recycling, and subsequently
the surface levels of TfR. The effects are attributable to the oligomeric form, but not monomeric
or ﬁbrillar form, of extracellular a-syn. Together, multiple alterations in membrane trafﬁcking by
secreted oligomeric a-syn may contribute to the early stages of pathogenesis in Parkinson’s disease.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Parkinson’s disease (PD) results primarily from the death of
dopaminergic neurons in the substantia nigra and aggregated
deposits termed Lewy bodies in the brain. The major component
of these intracellular deposits is aggregated a-synuclein (a-syn),
a 140-amino acid protein that is abundantly expressed in presyn-
aptic terminals [1–3]. a-Syn accumulation is known to be an early
step in the pathogenesis of both sporadic and inherited PD, but the
molecular mechanism of how a-syn is accumulated in the intracel-
lular deposits of Lewy bodies remains unclear [4].
Recent evidence suggests that overexpressed and/or misfolded
a-syn can be released into the extracellular space by unconven-
tional exocytosis or via exosomes and transit to other cells [5–7].
Indeed, secreted a-syn is readily detected in the plasma and CSF
of humans and in the culture media of neuronal cells [8]. The
cell-to-cell transfer of secreted a-syn consequently leads to an
accumulation of intracellular a-syn and precedes the misfolding
of small aggregates in the recipient cells [9–11].Membrane trafﬁcking plays a central role in the maintenance of
cell organization and organelle homeostasis, and for intercellular
communication [12,13]. Transferrin (Tfn)-mediated iron uptake
has been extensively studied as an example of intracellular traf-
ﬁcking. Upon binding of diferric transferrin (Fe2Tf) to transferrin
receptor (TfR), it transports iron into cells through receptor-medi-
ated endocytosis. The internalized iron is released from early endo-
somes into the cytoplasm within an acidic environment, whereas
Tfn and TfR recycle back to the cell surface at a neutral pH. Due
to this unique characteristic, TfR is used as an indicator for mem-
brane trafﬁcking pathways recycling between endosomes and the
plasma membrane [14,15].
A recent study showed that the overexpression of wild-type a-
syn and polyunsaturated fatty acids (PUFAs) increased vesicle
endocytosis and recycling in both neuronal and non-neuronal cells
[16], but there is still debate on whether secreted a-syn has any ef-
fect on membrane trafﬁcking in neighboring cells and if it does,
then which particular species of a-syn would be responsible for
that.
Here, we investigated the effects of secreted a-syn from dif-
ferentiated SH-SY5Y cells on membrane trafﬁcking by observing
the uptake of Tfn by receptor-mediated endocytosis. We further
investigated which forms of a-syn in aggregations are responsi-
ble for the effects of secreted a-syn uptake. Our ﬁndings may
provide valuable insights into possible new therapeutic strategies
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control PD.
2. Materials and methods
2.1. Preparation of cell extract and conditioned medium (CM)
Differentiated SH-SY5Y cells were infected with adenoviral vec-
tor expressing either human a-synuclein (a-syn) or b-galactosi-
dase (LacZ). Two days after infection, the growth media were
replaced with the serum-free media. After 18 h of incubation at
37 C, the conditioned media were collected and centrifuged at
1000g for 10 min, and subsequently, at 10000g for 10 min to re-
move cell debris and dead cells. The recovered supernatants were
concentrated using 10000 molecular weight cut-off ﬁlters (Milli-
pore, Billerica, MA).
For extraction of cellular proteins, the cells were washed ice-
cold phosphate-buffered saline (PBS) and harvested in the extrac-
tion buffer (PBS/1% Triton X-100/protease inhibitor cocktail). The
extract was centrifuged at 16000g for 10 min to obtain the Tri-
ton-soluble (supernatant) and insoluble (pellet) fractions. The pro-
tein samples (10 lg) were loaded onto 12% SDS–PAGE. The primary
antibody used for western analysis was monoclonal anti-a-synuc-
lein antibody, syn-1 (BD Biosciences, San Jose, CA), and anti-b-
galactosidase antibody (Developmental Studies Hybridoma Bank,
Univ. of Iowa, Iowa City, IA).
2.2. Thioﬂavin T binding assay
Forty microliters of each sample was mixed with 10 lM thioﬂa-
vin T solution in 10 lM glycine buffer (pH 8.5) and incubated at
room temperature for 5 min. Absorbance was measured with exci-
tation at 450 nm and emission at 490 nm with a SpectraMax GEM-
INI EM (Molecular Probes, Eugene, OR).
2.3. Circular dichroism (CD)
CD spectra of protein samples (0.5 mg/ml) were recorded from
190 to 260 nm with a step resolution of 1.0 nm, band width of
1.0 nm and an average time of 100 nm/min by using J-810 spectro-
polarimeter (Jasco, Mountain View, CA). For all spectra, an average
out of 10 separates measurements was obtained.
2.4. Electron microscopy (EM)
Each sample was dropped on the formvard-coated grids and
negatively stained with 1% (w/v) uranyl acetate. And then, samples
were washed with distilled water. Electron microscopy images
were obtained at 100 kV on a Philips CM electron microscope (Phi-
lips, Eindhoven, Netherlands).
2.5. Preparation of recombinant a-syn and aggregates
a-Syn expressed in Escherichia coli BL21 DE3 was puriﬁed using
sequential column chromatography, including anion exchange
(High-trap Q column, GE healthcare Life science, Pittsburgh, PA)
and size exclusion column chromatography (Sephacryl S-200, GE
healthcare Life science). Bacterial endotoxins were removed from
recombinant a-syn using the Toxineraser endotoxin removal kit
(Genscript, Piscotaway, NJ). Endotoxin levels were determined
using the Toxinsensor chromogenic LAL endotoxin assay kit (Gen-
script) (<0.015 endotoxin unit/1 mg of a-syn). For spontaneous
oligomerization, lyophilized recombinant a-syn was dissolved in
PBS (1 mg/ml) and incubated at 4 C. After two days of incubation,
protein was ﬁltrated using 100000 molecular weight cut-off cen-
trifugal ﬁlters (Millipore).2.6. Cell culture/ Tfn uptake and recycling assay
For Tfn uptake, COS-7 cells were grown on coverslips in DMEM
supplemented with 10% FBS and starved for 6 h in serum-free
DMEM before treatment with CM or control medium for 2 h. The
cells were further incubated in serum-free DMEM with 20 mM
HEPES containing 20 lg/ml Texas red Tfn (Molecular probe) for
10 min at 37 C, then washed with PBS, acid stripped (150 mM
NaCl, 2 mM CaCl2, and 25 mM CH3COONa, pH 4.5) on ice and
immediately ﬁxed in 4% paraformaldehyde. To study Tfn recycling
after continuous uptake, cells were incubated at 37 C in serum-
free DMEM/HEPES containing 20 lg/ml Texas red Tfn for 60 min,
then loaded with 100 lg/ml unlabeled Tfn (Sigma) and further
incubated at 37 C for various lengths of time. The cells were
washed with ice-cold PBS, acid stripped on ice and ﬁxed immedi-
ately. Images were taken on a Zeiss Axiovert microscope (Carl
Zeiss, Jena, Germany) using a 60, 1.25 N.A. oil lens and Hamama-
tsu OrcaII CCD camera (Hamamatsu Photonics, Hamamatsu City,
Japan). Texas red intensities were averaged over individual cells
and analyzed using MetaMorph Imaging software (Universal Imag-
ing Corp., West Chester, PA). Data are presented as means ± S.E.
Statistical analyses were carried out with SPSS statistics 18 (IBM
Corporation, Armonk, NY). For multiple conditions, we compared
means by ANOVA followed by Turkey’s HSD post hoc test.
2.7. Immunostaining of a-syn
COS-7 cells were starved for 6 h in serum-free DMEM and trea-
ted with CM in the presence or absence of 40 lM of DD-11 for 2 h,
and ﬁxed. The cells were incubated at 4 C in a-synuclein 274 anti-
body, which reacts only to human a-syn (1:500 in PBS/3% BSA) fol-
lowed by incubation with the anti-Mouse Oregon green antibody
(1:1000 in PBS/3% BSA, Molecular Probes) for 45 min. Detailed pro-
cedures for production and characterization of this monoclonal hu-
man speciﬁc a-syn antibody have been described previously
[17,18].
2.8. Measurement of cell surface TfR/TIRF microscopy
Surface levels of TfR were determined in the presence of 50 lg/
ml of cychloheximide (Sigma). COS-7 cells were starved for 6 h and
preincubated with 50 lg/ml of cychloheximide for 1 h before the
treatment of CM or control medium, which contained 50 lg/ml
of cychloheximide in serum-free DMEM for 2 h. The cells were
washed with ice-cold PBS and incubated in serum-free DMEMwith
20 mMHEPES containing 20 lg/ml Texas red Tfn at 4 C for 10 min.
Unbound Tfn was removed by washing with PBS and ﬁxed in 4%
paraformaldehyde. For total internal reﬂection ﬂuorescence (TIRF)
microscopy, cells were imaged using an Olympus IX-71microscope
ﬁtted with a 60  1.45 N.A. TIRF lens and controlled by CellM
software (Olympus, Tokyo, Japan). Laser line (488 nm diode laser)
was coupled to the TIRFM condenser through an optical ﬁber.
The calculated evanescent depth was 150 nm. Cells were
typically imaged with 0.1–0.2 s exposures and detected with
back-illuminated Andor iXon887 EMCCD camera (512  512,
16-bit; Andor Technologies, Belfast, UK). MetaMorph Imaging
Software was used for analysis.
2.9. Mathematical analysis
Mathematical models of the experimental data were con-
structed as systems of ordinary differential equations (ODEs), cor-
responds to a distinguishable biological state of the TfR. The
models were coded in MATLAB version 7.40 (MathWorks, Natick,
MA) and solved using the ode45 functions.
The mathematical models for the TfR are as follows:
Fig. 1. Secreted a-syn is transferred by dynamin-dependent endocytosis. (A) Immunocytochemistry with anti-a-syn 274 antibody performed on COS-7 cells, which were
treated with control medium or CM in the absence or presence of 40 lM of DD-11 for 2 h at 37C.
Fig. 2. Secreteda-syn increases the rate of Tfn internalization. (A) Representative images of Tfn internalization for the control (top panel) anda-syn (bottompanel) with various
time points in COS-7 cells. Single-round kinetics of Tfn uptake were determined for the indicated time. (B) Average ﬂuorescence intensity was measured at each time point.
Mean of 15 cells ± S.E. in each independent experiment were measured by selecting the region of interest to the cell area, n = 5, ⁄P < 0.05, Student’s t-test. Linear ﬁtted graphs
were obtained from each average ﬂuorescence intensity. (C) Endocytic rate was measured with t1/2 = 5.403 ± 0.26 min for the control, t1/2 = 4.203 ± 0.21 min for the a-syn.
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dt
¼ k3TfRM2 k1TfRM1 ð1Þ
dTfRE
dt
¼ k1TfRM1 k2TfRME ð2Þ
dTfRM2
dt
¼ k2TfRE k3TfRM2 ð3Þ
where k1, k2, k3 are the rate constants for each condition and
TfRM1, TfRE and TfRM2 are the arbitrary units of TfR at the plasma
membrane, the TfR in the endosomal compartments when it isinternalized and the TfR at the plasma membrane once it is recycled
respectively. (See ‘‘section 3’’ for a description of receptor states).
3. Results
3.1. Secreted a-syn is taken up by dynamin-dependent endocytosis
Secreted a-syn in conditioned medium (CM) was obtained from
differentiated SH-SY5Y cells, infected with an adenoviral vector
expressing either human a-syn or b-galactosidase (LacZ) (Supple-
mental Fig. 1). To test whether this secreted a-syn enters cells by
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rescence staining of a-syn in COS-7 cells with the endocytosis
inhibitor of DD-11, a potent inhibitor of the GTPase activity of dyn-
amin [19] (Supplemental Fig. 2). Fig. 1 clearly demonstrates that
the secreted a-syn is taken up by dynamin-dependent endocytosis
because DD-11 almost completely inhibits a-syn uptake into COS-
7 cells (Fig. 1A).
3.2. Secreted a-syn enhances the rate of Tfn internalization
To investigate a possible role of secreted a-syn in membrane
trafﬁcking, we performed a Tfn uptake assay [20,21]. Tfn is inter-
nalized through receptor-mediated endocytosis, shown in Fig. 2A
at each time point [22]. We found that Tfn internalization was sig-
niﬁcantly increased with treatment of CM compared to the control
groups (t1/2 = 5.403 ± 0.26 min for the control, t1/2 = 4.203 ±
0.21 min for the a-syn), indicating that the secreted a-syn in CM
increased the rate of Tfn internalization (Fig. 2B, C). The concentra-
tion of a-syn in CM used in the experiments was 0.486 lg/ml
(33.5 nM), and we found that with lower concentration of
a-syn, the effect on Tfn internalization did not reach statistical
signiﬁcance (Supplemental Fig. 3).
3.3. Secreted a-syn enhances the rate of Tfn recycling
To test the effect of secreted a-syn in CM on Tfn recycling after
internalization, COS-7 cells were loaded with 20 lg/ml of Texas red
Tfn in serum-free DMEM/HEPES at 37 C for 60 min to saturate theFig. 3. Secreted a-syn increases the rate of Tfn recycling. (A) Representative images of Tfn
the endosome was measured at indicated time. (B) Average ﬂuorescence intensity of Tex
experiment were measured by selecting the region of interest to the cell area, n = 6,⁄P < 0
graphs, ﬁtted by a single exponential for each condition. (C) Recycling rate was measureentire endocytic recycling pathway and 100 lg/ ml of unlabeled
Tfn was subsequently added and incubated at 37 C at indicated
time, shown in Fig. 3A [22]. The quantiﬁcation of average intensity
showed that secreted a-syn signiﬁcantly enhanced the Tfn recy-
cling compared to the control (t1/2 = 13.832 ± 1.17 min for the con-
trol and t1/2 = 10.678 ± 0.83 for the a-syn, Fig. 3C). The initial
average ﬂuorescence intensity with the secreted a-syn at 0 min
was signiﬁcantly lower than that with control (494.73 ± 63.86 for
the a-syn and 592.01 ± 58.41 for the control, Fig. 3B), suggesting
less accumulation of Tfn in the endosomal compartment, which
correlates well with faster Tfn recycling in cells with secreted a-
syn.
3.4. Mathematical modeling of TfR trafﬁcking estimates that secreted
a-syn increases the levels of TfR at the cell surface
Based on our observed data from the TfR trafﬁcking, we con-
structed a mathematical model of experimental data using a sys-
tem of ordinary differential equations to estimate the levels of
TfR at the cell surface. The schematic diagram of our model is
shown in Fig. 4A. We suggested that one cycle of the TfR trafﬁcking
occurs within 30 min and both the a-syn-treated cells and control
cells initially have the same number of TfR at the cell surface. Using
t1/2 values that we measured in Figs. 2C and 3C, we were able to
track the TfR in each condition (Fig. 4B and C for the control and
a-syn, respectively). The results clearly demonstrated that a-syn
treated cells would have higher surface levels of TfR than that of
control (Fig. 4D).recycling for the control (left) and a-syn (right) in COS-7 cells. Recycling of Tfn from
as red was measured at each time point. Mean of 20 cells ± S.E. in each independent
.05, Student’s t-test. The inset shows the normalized average ﬂuorescence intensity
d with t1/2 = 13.832 ± 1.17 min for the control and t1/2 = 10.678 ± 0.83 for the a-syn.
Fig. 4. Mathematical modeling estimates the number of cell surface TfR. (A) A schematic diagram of the TfR trafﬁcking, where TfR is internalized from the cell surface and
recycled back to the plasma membrane as functions of time. (B, C) The time course of TfR in each condition with rate constants k1, k2 and k3 for the control and a-syn-treated
cells. TfRM1, TfR at the cell surface; TfRE, TfR in the endosomal compartment; TfRM2, TfR at the plasma membrane once it is recycled back to the cell surface. (D) The
theoretical TfR surface occupancy (TfRM1 + TfRM2) was solved over time.
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To determine the TfR levels at the cell surface, we preincubated
cells with 50 lg/ml of cychloheximide (CHX) for 2 h [23], which
inhibits protein synthesis to eliminate possible complications
caused by a-syn effects on TfR synthesis, and the total internal
reﬂection ﬂuorescence microscopy (TIRFM) was used to selectively
visualize the cell surface TfR for each condition (Fig. 5A). The num-
ber of puncta/100 lm2 of TfR at the cell surface in COS-7 cells trea-
ted with CM was increased approximately threefold compared to
the control (the number of puncta/100 lm2 = 7.683 for the control
and the number of puncta/100 lm2 = 22.103 for the a-syn, Fig. 5B)
while the total level of TfR was not affected (Fig. 5C).
3.6. Soluble oligomeric secreted a-syn enhances Tfn internalization
We next tested which species of a-syn in aggregations are
responsible for the effects of secreted a-syn in CM. Since our CM
was a mixture of the monomeric, oligomeric and ﬁbrillar forms,
it is uncertain which particular species of a-syn affected mem-
brane trafﬁcking in recipient cells. Thus, we prepared media con-
taining recombinant a-syn in aggregations restricted to
monomeric, ﬁbrillar and oligomeric forms (Supplemental Fig. 4
and 5). The result showed that there is no signiﬁcant difference
in the Tfn internalization for the monomeric or ﬁbrillar formscompared to the control (Fig. 6A and B), suggesting that the soluble
oligomeric form of a-syn in CM may be responsible for the effects
of a-syn on membrane trafﬁcking in recipient cells.
To further corroborate this, we next prepared a mixture of a-
syn monomers and oligomers and ﬁltered to separate the mono-
mers and oligomers in the mixture (Supplemental Fig. 6), which
was then tested subsequently for effects on Tfn uptake. While ﬁl-
tered monomers (0.2 lM) failed to affect Tfn uptake, the oligomers
(0.2 lM) of a-syn enhanced Tfn internalization compared to the
control, indicating the role of the soluble oligomeric form of a-
syn in Tfn internalization (Fig. 6C and D).
4. Discussion
There is an emerging body of evidence suggesting that a-syn
can be secreted in the extracellular space, affecting the homeosta-
sis of recipient cells, possibly by the cell-to-cell transfer mecha-
nism. Recent studies showed that low nanomolar concentrations
of monomeric and oligomeric a-syn have been detected in human
cerebrospinal ﬂuids (CSF) and blood plasma from PD patients, fur-
ther emphasizing concerns about the secreted a-syn in the extra-
cellular space [24–26].
A few mechanisms such as via exosome or tunneling nanotubes
formation have been suggested as to how secreted a-syn transfers
between cells [27,28] and our results clearly demonstrate that
Fig. 5. Secreted a-syn increases the levels of cell surface TfR. (A) Representative TIRF images of cell surface TfR levels for the control (left) and a-syn (right). The levels of cell
surface TfR were measured by using cycloheximide. Scale bar = 20 lm. (B) The number of puncta per 100 lm2 of the TfR in COS-7 was quantiﬁed, n = 5, ⁄P < 0.01, Student’s t-
test. (C) Cos-7 cells were serum-starved for 6 h and treated with CM or control medium for 2 h. Cell lysates were processed for SDS–PAGE and a western blot analysis was
performed with anti-TfR antibody.
Fig. 6. Soluble oligomer a-syn enhances the Tfn internalization. (A) Representative images of each aggregation form are shown. Tfn uptake assay was carried out for 10 min at
37 C with 0.2 lM of monomeric and ﬁbrillar forms of a-syn. (B) Average ﬂuorescence intensity was quantiﬁed for each condition, n = 5 ⁄P < 0.05, Student’s t-test. (C)
Representative images of Tfn internalization for each aggregation form of a-syn: ﬁltered monomer and oligomer with control medium. Scale bar = 20 lm. (D) Average
ﬂuorescence intensity was quantiﬁed for each condition, n = 10 one-way ANOVA followed by the Tukey’s HSD post hoc test, ⁄p < 0.05.
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dependent endocytosis rather than other mechanism suggested
(Fig. 1). The Tfn uptake and release assays have shown that the
recycling of Tfn back to the plasma membrane as well as the Tfn
internalization is affected by secreted a-syn, indicating that the se-
creted a-syn induces multiple alterations in membrane trafﬁcking
(Figs. 2 and 3). Moreover, we show that secreted a-syn enhances
the levels of cell surface TfR. Although how endocytosed a-syn is
released into the cytoplasm of the recipient cells remains unsolved
[28], our results suggest that exogenous treatment of secreted a-
syn affects various steps in membrane trafﬁcking pathways.
A recent study suggested that the overexpression of a-syn
inhibits synaptic vesicle (SV) exocytosis and reduces the recycling
fraction of SVs by inhibiting SV reclustering after endocytosis [29].
Our results of a-syn-induced fast endocytosis followed by fast
recycling and a high surface resident fraction of TfR seem to be
contradictory to their results. Although this may be due to different
systems used (COS-7 cells vs. cultured neurons), we noticed that
they measured the extent of exocytosis but did not test for the
kinetics of SV recycling or for the surface resident fraction of SVs
[29]. Therefore, we assume that the defects in SV reclustering
and reduced recycling fraction of SVs they observed may be due
to a high surface fraction of SVs which are less likely to be recycled,
which is consistent with our current results on TfR recycling, rather
than SV reclustering defect itself although this requires further
study.
The central issues associated with secreted a-syn are which
species of a-syn are effectively internalized by recipient cells and
initiate the intracellular toxic effects. Emmanouilidou et al.
(2010) and Desplats et al. (2009) have shown that high n-oligo-
meric a-syn in conditioned medium from WT- expressing SH-
SY5Y cells can decrease cell viability and exert much greater cyto-
toxicity in recipient cells compared to the soluble monomeric a-
syn [7,9]. Park et al. (2009) reported that monomeric a-syn was
internalized into microglia in a clathrin-, caveolae-, and dynam-
in-independent manner but, it was dependent on lipid rafts and
ganglioside GM1, suggesting that monomeric a-syn was internal-
ized into microglia via another less characterized pathway [30].
Other studies, however, suggest that monomeric a-syn can directly
translocate through the plasmamembrane, accounting for the pen-
etration of monomeric a-syn into cells while a-syn forms with
higher molecular weight, ﬁbrils and oligomers were internalized
through an endocytic pathway [31,32]. Moreover, monomeric a-
syn is internalized into neuronal cells in a temperature-indepen-
dent manner, whereas aggregated a-syn is internalized into the
cells by a temperature-dependent endocytosis mechanism, further
supporting the idea that secreted a-syn may be internalized by dif-
ferent routes, depending on its assembly state or cell-type-speciﬁc
mechanisms.
Our current results suggest that accumulation and internaliza-
tion of the secreted oligomeric species of a-syn, rather than mono-
meric or ﬁbrillar forms, effectively induce multiple alterations in
membrane trafﬁcking. Elucidating the possible mechanism how
secreted oligomeric forms of a-syn are accumulated and may in-
duce multiple alterations in membrane trafﬁcking would be
greatly helpful for the development of new therapeutic strategies
and the treatment of a-syn-related neuronal degeneration in PD.
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